John Kloetzing
Owner & Managing Director, Kloetzing Transformation Partners UG
John Kloetzing
Owner & Managing Director, Kloetzing Transformation Partners UG
John Kloetzing is a supply chain transformation leader with more than 13 years of experience across pharmaceuticals and consumer goods. He has led international planning, S&OP and business transformation initiatives across Europe, North America and Asia, combining strategic direction with hands-on execution. His work focuses on building decision-ready organizations, strengthening cross-functional collaboration and translating complexity into clear operational choices. John has held senior roles at Bayer and Heineken and has extensive experience in scenario planning, integrated business planning, launch readiness and digital transformation. He is currently completing a Global MBA at ESMT Berlin and is the founder of Kloetzing Transformation Partners, advising organizations on supply chain strategy, AI-enabled decision architecture and leadership under uncertainty.
Vera Hazelwood
Director, Data Science Collaborative Programmes, AstraZeneca
Vera Hazelwood
Director, Data Science Collaborative Programmes, AstraZeneca
Vera H is a Learning & HR Technology professional with expertise in human resources, talent development, and HR digital transformation. She currently works at PT Sinergy Informasi Pratama, where she focuses on enhancing HR information systems, leveraging AI-driven solutions, and supporting organizational development initiatives. With a background in psychology and data analytics, Vera combines people-centric strategies with technology to improve workforce performance and business outcomes. Her experience spans talent acquisition, learning and development, HR operations, and process improvement. Passionate about continuous learning, she is committed to building innovative HR practices, driving organizational growth, and creating data-informed solutions that support both employee development and long-term business success.
Ashish Chandra Saxena
Global Capability Owner (GCO)- Customer Targeting & Engagement Planning, Boehringer Ingelheim
Ashish Chandra Saxena
Global Capability Owner (GCO)- Customer Targeting & Engagement Planning, Boehringer Ingelheim
With over three decades of extensive international experience in the pharmaceutical industry, Ashish Saxena has held diverse leadership roles across Sales, Training, Sales Force Effectiveness, Commercial Excellence, Digital Transformation, Market Research and Analytics. His career encompasses both operational execution and strategic leadership, fostering a comprehensive and multidimensional expertise in pharmaceutical business complex landscape. Currently based in Germany, Ashish works as the Global Capability Owner at Boehringer Ingelheim, where he leads the global function for Customer Targeting and Engagement Planning. In this role, he is responsible for shaping the global vision and strategy, collaborating with regional and country teams worldwide. He spearheads cross-functional initiatives to develop frameworks, processes, and tools that enable effective segmentation, targeting, and engagement of healthcare professionals (HCPs) and healthcare organizations (HCOs), ensuring alignment with evolving healthcare landscapes and the dynamic business environment.
Serena Saggini
Director, Sophos Biotech
Serena Saggini
Director, Sophos Biotech
A Harvard-graduated Director, she boasts over 25 years of exceptional commercial success in Biotech, Rare Diseases, Oncology, and CNS across top-tier pharma leaders like Sanofi, Genzyme, GSK, and Ferring. Recognized for a highly innovative approach, she pioneers AI-driven market analysis and builds high-performing business units from scratch. Her career is anchored in absolute patient-centricity, demonstrated by a proven track record of forging strong partnerships with patient associations, institutions and scientific societies. Honored of the 2026 Leadership Excellence Award, she practices 360-degree leadership that bridges cross-functional teamwork with strategic/commercial growth. She is also regular keynote speaker at prestigious global digital and commercial excellence summits.
Denis Morgenthaler
Transformation Architect, Bayer AG
Denis Morgenthaler
Transformation Architect, Bayer AG
With over 24 years in pharmaceuticals and industry, I am a purpose-driven leader dedicated to patient impact and organizational transformation.
Following early experience at Volkswagen and Accenture, I spent over two decades at Bayer Pharma, advancing from CDMO procurement to leading global supply management for Biotech, Radiology, and Steriles & Devices across Berlin, Basel, Barcelona, and Pittsburgh.
Since 2023 I serve as a Dynamic Shared Ownership (DSO) Transformation Architect, designing agile operating models that empower networked teams.
Additionally, as a Lecturer in Practice at Quadriga University Berlin, I bridge industry and academia—teaching supply chain / operations management , business / digital transformation and executive leadership.
Hiram Baker
CEO/Founder, Baker Industries LLC
Hiram Baker
CEO/Founder, Baker Industries LLC
Hiram Baker is an experienced business leader and the Chief Executive Officer of Baker Industries L.L.C., an operations consulting firm focused on providing comprehensive solutions across funding, real estate, executive staffing, investments, technology, marketing, and strategic growth initiatives for businesses of all sizes. In his role, Hiram leverages extensive client and partner relationships to drive business development, operational excellence, and innovative problem-solving strategies. With a strong entrepreneurial mindset, he guides Baker Industries in delivering tailored support that enhances organizational performance and accelerates growth outcomes. His background reflects a commitment to scalable, client-centric service and the development of unique approaches to complex business challenges.
George Lellis
arketing & Commercial AI Transformation Strategist CFCIM | FIDM | SAFe
George Lellis
arketing & Commercial AI Transformation Strategist CFCIM | FIDM | SAFe
George Lellis is an innovator at heart embracing AI long before the AI has been known to the world. As an accomplished global marketing strategist and commercial AI transformation leader with experience on multiple fronts in Fortune 500 consumer goods, pharma, and medtech companies across EMEA, LATAM, APAC & Americas, he can uniquely join the dots between company brand, data, product portfolio, customer experience, and 360-degree sustainable business growth. He advises commercial leaders on long-term strategy, international development, and business agility. George's DNA could have led him to become an internist but preferred to diagnose and propose treatment plans for businesses instead of patients. Yet, he always cares for positive patient and business outcomes by designing omnichannel journeys and better orchestrating sales efforts to KOLs and HCPs with machines as much as with people.
Michael Dreiseidler, PhD
Medical Affairs Lead, Novartis
Michael Dreiseidler, PhD
Medical Affairs Lead, Novartis
Michael Dreiseidler, PhD, is a senior Medical Affairs leader with more than 12 years of experience in the pharmaceutical industry across clinical operations and medical affairs. He currently works in hematology, with a particular focus on evidence strategy, scientific engagement and the translation of clinical evidence into meaningful impact in patient care. Over the course of his career, Michael has held roles spanning clinical research, field medical and medical strategy, giving him a broad perspective on how evidence is generated, interpreted and ultimately applied in clinical practice. His current interests include real-world evidence, evidence gap identification, implementation science and the distinction between evidence required for regulatory or HTA purposes and evidence needed to support clinical adoption and decision-making.
Neha Dave
Government Affairs Advisor
Neha Dave
Government Affairs Advisor
Neha Dave is an independent consultant specialising in EU Government Relations and Public Affairs, with a strong focus on the life sciences sector, including healthcare, pharmaceuticals, and medical technology. With extensive expertise in navigating the EU political and regulatory landscape, Neha supports key industry stakeholders in understanding legislative developments, engaging with policymakers, and facilitating high-level discussions on critical issues shaping the future of life sciences. Her areas of expertise include Artificial Intelligence, digital transformation, resilience, international trade, sustainability, market access, and healthcare policy. She provides strategic counsel to pharmaceutical and life sciences leaders on emerging challenges such as AI regulation, geopolitical shifts, trade and supply chain disruptions, most-favoured-nation pricing, and evolving environmental policies. With AI and digital transformation increasingly shaping the European life sciences landscape, Neha brings valuable perspectives on the intersection of technology, policy, regulation, and industry strategy.
Ahmed El Azhary
Market Access & Public Affairs Director, UAE & Gulf, Merck Healthcare
Ahmed El Azhary
Market Access & Public Affairs Director, UAE & Gulf, Merck Healthcare
Ahmed El Azhary has extensive experience in the healthcare industry. Throughout his 20-year professional journey, he has held several leadership positions in Market Access, Marketing, Sales, Innovation, and Digital Transformation at multinational pharmaceutical companies. Currently, he leads the Market Access & Public Affairs department at Merck Healthcare across the Gulf countries, aiming to improve access to medicines and innovative solutions that positively impact patients’ lives and the healthcare community. His key areas of interest include Strategy, Leadership, and Healthcare Innovation.
Reinhold Schilling, M.D.R.A.
Head of Global Pharmacovigilance, QPPV EU, Stufenplanbeauftragter, Wörwag Pharma GmbH & Co. KG
Reinhold Schilling, M.D.R.A.
Head of Global Pharmacovigilance, QPPV EU, Stufenplanbeauftragter, Wörwag Pharma GmbH & Co. KG
Reinhold Schilling is Head of Global Pharmacovigilance, EU QPPV and Stufenplanbeauftragter at Wörwag Pharma. He leads global pharmacovigilance activities with a strong focus on patient safety, regulatory compliance and effective oversight of international PV processes. Beyond pharmacovigilance, he actively supports companies in enabling the responsible and practical adoption of artificial intelligence, bridging technology, governance and real-world business processes. His particular interest lies in moving AI beyond experimentation toward controlled, auditable and human-centered applications in regulated environments. In addition to his industry role, Reinhold teaches in the Pharma MBA program at Goethe Business School and at Reutlingen University, sharing his experience in pharmacovigilance, digital transformation and the responsible application of AI.
Dr. Martijn Kelder
Chief Strategy Officer, Annogen B.V.
Dr. Martijn Kelder
Chief Strategy Officer, Annogen B.V.
Dr. Martijn Kelder is Chief Strategy Officer at Annogen B.V., an Amsterdam-based biotechnology company developing bespoke cell- and tissue-specific promoters. Annogen’s proprietary SuRE platform uses a barcoded massively parallel reporter assay to identify regulatory elements that drive gene expression in specific cell types, with Annogen promoters being used in clinical-stage therapies. Dr. Kelder holds a PhD from the University of Edinburgh, where he worked on genome editing, and a master’s degree in cancer genomics from Utrecht University. Before joining Annogen, he served as Commercial Director and was part of the management team at Cergentis. At Annogen, he leads scientific strategy, business development, and partnering across biopharma and agricultural applications.